Rapid Micro Biosystems (RPID) Change in Accured Expenses (2020 - 2026)

Rapid Micro Biosystems has reported Change in Accured Expenses for 7 years, with the latest figure at -$2.2 million in Q1 2026.

• Quarterly Change in Accured Expenses fell 11.43% year-over-year to -$2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$201000.0 (up 92.82% YoY) and the FY2025 annual result came in at $28000.0, up 100.72% from the prior year.
• Change in Accured Expenses retreated to -$2.2 million in Q1 2026 per RPID's latest filing, from $1.1 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $2.9 million in Q4 2023 and troughed at -$3.9 million in Q1 2022.
• A 5-year average of -$436470.6 and a median of -$439000.0 in 2024 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses plunged 396.8% in 2022, then soared 28860.0% in 2023.
• Over 5 years, Change in Accured Expenses stood at $10000.0 in 2022, then jumped by 28860.0% to $2.9 million in 2023, then sank by 115.16% to -$439000.0 in 2024, then jumped by 349.89% to $1.1 million in 2025, then sank by 303.46% to -$2.2 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered -$2.2 million, $1.1 million, and $599000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.